These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9176927)
1. Chronic haloperidol treatment does not affect structure of attention in schizophrenia. Allen DN; Gilbertson MW; van Kammen DP; Kelley ME; Gurklis JA; Barry EJ Schizophr Res; 1997 May; 25(1):53-61. PubMed ID: 9176927 [TBL] [Abstract][Full Text] [Related]
2. Continuous performance tests in schizophrenic patients: stimulus and medication effects on performance. Earle-Boyer EA; Serper MR; Davidson M; Harvey PD Psychiatry Res; 1991 Apr; 37(1):47-56. PubMed ID: 1862161 [TBL] [Abstract][Full Text] [Related]
4. Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes. Allen DN; Anastasiou A; Goldstein G; Gilbertson M; van Kammen DP Psychiatry Res; 2000 Feb; 93(1):33-9. PubMed ID: 10699226 [TBL] [Abstract][Full Text] [Related]
5. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109 [TBL] [Abstract][Full Text] [Related]
7. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol. Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652 [TBL] [Abstract][Full Text] [Related]
8. Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia. Gilbertson MW; van Kammen DP Biol Psychiatry; 1997 Oct; 42(7):585-95. PubMed ID: 9376455 [TBL] [Abstract][Full Text] [Related]
9. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings. Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840 [TBL] [Abstract][Full Text] [Related]
10. Clonidine plus haloperidol in the treatment of schizophrenia/psychosis. Maas JW; Miller AL; Tekell JL; Funderburg L; Silva JA; True J; Velligan D; Berman N; Bowden CL J Clin Psychopharmacol; 1995 Oct; 15(5):361-4. PubMed ID: 8830068 [TBL] [Abstract][Full Text] [Related]
11. Medication may be required for the development of automatic information processing in schizophrenia. Serper MR; Bergman RL; Harvey PD Psychiatry Res; 1990 Jun; 32(3):281-8. PubMed ID: 2388967 [TBL] [Abstract][Full Text] [Related]
12. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder. Goff DC; Posever T; Herz L; Simmons J; Kletti N; Lapierre K; Wilner KD; Law CG; Ko GN J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695 [TBL] [Abstract][Full Text] [Related]
14. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Peuskens J Br J Psychiatry; 1995 Jun; 166(6):712-26; discussion 727-33. PubMed ID: 7545060 [TBL] [Abstract][Full Text] [Related]
15. A double-blind study of adjunctive sertraline in haloperidol-stabilized patients with chronic schizophrenia. Lee MS; Kim YK; Lee SK; Suh KY J Clin Psychopharmacol; 1998 Oct; 18(5):399-403. PubMed ID: 9790158 [TBL] [Abstract][Full Text] [Related]
16. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Lee SM; Chou YH; Li MH; Wan FJ; Yen MH Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386 [TBL] [Abstract][Full Text] [Related]
17. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911 [TBL] [Abstract][Full Text] [Related]
19. The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers. McCartan D; Bell R; Green JF; Campbell C; Trimble K; Pickering A; King DJ J Psychopharmacol; 2001 Jun; 15(2):96-104. PubMed ID: 11448094 [TBL] [Abstract][Full Text] [Related]
20. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Yamashita H; Morinobu S; Yamawaki S; Horiguchi J; Nagao M Psychiatry Res; 2002 Mar; 109(2):137-42. PubMed ID: 11927138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]